[ad_1]
new York, July 16, 2021 /PRNewswire/ – Pomerantz LLP announced that it has acquired Ocugen, Inc. (“Ocugen” or “Company”) (NASDAQ:OCGN) And some of its senior staff.Class action, filed at United States Eastern District Court Pennsylvania, And recorded under 21-cv-03182, representing a category composed of all individuals and entities other than the defendant who are in February 2, 2021, with June 10, 2021, Including (“Class Action Period”), seeking compensation for damages caused by violations of the Federal Securities Act under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (“Exchange Act”), and rules 10b-5 Promulgated accordingly, targeting the company and some of its senior officials.
If you are a shareholder who purchased or otherwise acquired Ocugen securities during a class action, you must August 17, 2021 Ask the court…
The full story on Benzinga.com
[ad_2]
Source link
